The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 417-423, February 2009

Household peanut consumption as a risk factor for the development of peanut allergy

  • Adam T. Fox, FRCPCH

      Affiliations

    • King's College London, the Medical Research Council and Asthma UK Centre in Allergic Mechanisms of Asthma, Division of Asthma, Allergy and Lung Biology, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom
  • ,
  • Peter Sasieni, PhD

      Affiliations

    • Queen Mary University of London, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, London, United Kingdom
  • ,
  • George du Toit, FRCPCH

      Affiliations

    • King's College London, the Medical Research Council and Asthma UK Centre in Allergic Mechanisms of Asthma, Division of Asthma, Allergy and Lung Biology, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom
  • ,
  • Huma Syed, PhD

      Affiliations

    • Queen Mary University of London, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, London, United Kingdom
  • ,
  • Gideon Lack, FRCPCH

      Affiliations

    • King's College London, the Medical Research Council and Asthma UK Centre in Allergic Mechanisms of Asthma, Division of Asthma, Allergy and Lung Biology, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom
    • Corresponding Author InformationReprint requests: Gideon Lack, FRCPCH, Department of Paediatric Allergy, St Thomas' Hospital, Lambeth Palace Rd, London SE1 7EH, United Kingdom.

Received 25 September 2008; received in revised form 11 December 2008; accepted 15 December 2008.

Background

Most children with peanut allergy (PA) react on first known oral exposure to peanut. Recent data suggest cutaneous exposure as a route of sensitization.

Objectives

This study aimed to establish the relevant route of peanut exposure in the development of allergy.

Methods

Questionnaires were administered to children with PA and to high-risk controls (with egg allergy) and controls without allergy. Questionnaires were completed before subjects were aware of their PA status, avoiding recall bias. Questionnaires recorded maternal peanut consumption during pregnancy, breast-feeding, and the first year of life. Peanut consumption was determined among all household members, allowing quantification of environmental household exposure (household peanut).

Results

Median weekly household peanut in the 133 PA cases was significantly elevated (18.8 g) compared with 150 controls without allergy (6.9 g) and 160 high-risk controls (1.9 g). There were no differences in infant peanut consumption between groups. Differences in maternal peanut consumption during pregnancy (and lactation) were significant but become nonsignificant after adjusting for household peanut. A dose-response relationship was observed between environmental (nonoral) peanut exposure and the development of PA, which was strongest for peanut butter. Early oral exposure to peanut in infants with high environmental peanut exposure may have had a protective effect against the development of PA.

Conclusions

High levels of environmental exposure to peanut during infancy appear to promote sensitization, whereas low levels may be protective in atopic children. No effect of maternal peanut consumption during pregnancy or lactation is observed, supporting the hypothesis that peanut sensitization occurs as a result of environmental exposure.

Key words: Allergy, children, food allergy, peanut allergy, sensitization, peanut consumption, cutaneous exposure, environmental exposure

Abbreviations used: EA, Egg allergy, PA, Peanut allergy, SPT, Skin prick test, UK, United Kingdom

 

 Supported by a research grant from the Food Standards Agency (United Kingdom; T07043). This grant supported the project costs, including the salary of A.T.F. over the study duration. G.L.'s salary was supported in part by the Aimwell Foundation.

 Disclosure of potential conflict of interest: G. Lack has provided consultation for the advisory boards of Synovate, Novartis Xolair, and ALK-Abelló; has served as an academic lecturer for SHS Nutricia, Nestlé, and SHS International; has received research support from the Immune Tolerance Network, the National Peanut Board, the Food Standards Agency, the Medical Research Council, the Food Allergy and Anaphylaxis Network, and the Food Allergy Initiative; and has served as a scientific advisor for the Anaphylaxis Campaign and the National Peanut Board. A. T. Fox has served as a consultant for SHS Nutricia and has attended a conference for Nestlé. P. Sasieni has received research support from Cancer Research, United Kingdom. G. du Toit has received research support from the National Peanut Board, USA, and the Immune Tolerance Network, National Institutes of Health. The other author has declared that she has no conflict of interest.

PII: S0091-6749(08)02431-7

doi:10.1016/j.jaci.2008.12.014

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 417-423, February 2009